Teva Of Israel Sued By Novartis Of Switzerland Over Patent Violation
This article was originally published in PharmAsia News
Executive Summary
Israel's Teva Pharmaceutical Industries has been sued in a U.S. court by Swiss-based Novartis, accusing it of infringing on patents for an organ-rejection drug